Fig. 2From: The subacute toxicity and underlying mechanisms of biomimetic mesoporous polydopamine nanoparticlesThe in vivo toxicity of MPDA nanoparticles. (A, B, C, D) The performance of various blood indexes under different concentrations of MPDAs-treated groups (78.57 mg/kg MPDA, 10.87 mg/kg MPDA, and 3.61 mg/kg MPDA). (E) Line plot of body weight change from day 2 to day 6 in each MPDAs treatment group. (F, G, H, I, J) The organ index of heart, liver, spleen, lung, and kidney, ** p < 0.01, * p < 0.05 compared with Control groupBack to article page